Unravelling cell type-specific responses to Parkinson’s Disease at single cell resolution

Abstract Parkinson’s Disease (PD) is the second most common neurodegenerative disorder. The pathological hallmark of PD is loss of dopaminergic neurons and the presence of aggregated α-synuclein, primarily in the substantia nigra pars compacta (SNpc) of the midbrain. However, the molecular mechanism...

Full description

Bibliographic Details
Main Authors: Araks Martirosyan, Rizwan Ansari, Francisco Pestana, Katja Hebestreit, Hayk Gasparyan, Razmik Aleksanyan, Silvia Hnatova, Suresh Poovathingal, Catherine Marneffe, Dietmar R. Thal, Andrew Kottick, Victor J. Hanson-Smith, Sebastian Guelfi, William Plumbly, T. Grant Belgard, Emmanouil Metzakopian, Matthew G. Holt
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Molecular Neurodegeneration
Online Access:https://doi.org/10.1186/s13024-023-00699-0
_version_ 1797233273985826816
author Araks Martirosyan
Rizwan Ansari
Francisco Pestana
Katja Hebestreit
Hayk Gasparyan
Razmik Aleksanyan
Silvia Hnatova
Suresh Poovathingal
Catherine Marneffe
Dietmar R. Thal
Andrew Kottick
Victor J. Hanson-Smith
Sebastian Guelfi
William Plumbly
T. Grant Belgard
Emmanouil Metzakopian
Matthew G. Holt
author_facet Araks Martirosyan
Rizwan Ansari
Francisco Pestana
Katja Hebestreit
Hayk Gasparyan
Razmik Aleksanyan
Silvia Hnatova
Suresh Poovathingal
Catherine Marneffe
Dietmar R. Thal
Andrew Kottick
Victor J. Hanson-Smith
Sebastian Guelfi
William Plumbly
T. Grant Belgard
Emmanouil Metzakopian
Matthew G. Holt
author_sort Araks Martirosyan
collection DOAJ
description Abstract Parkinson’s Disease (PD) is the second most common neurodegenerative disorder. The pathological hallmark of PD is loss of dopaminergic neurons and the presence of aggregated α-synuclein, primarily in the substantia nigra pars compacta (SNpc) of the midbrain. However, the molecular mechanisms that underlie the pathology in different cell types is not currently understood. Here, we present a single nucleus transcriptome analysis of human post-mortem SNpc obtained from 15 sporadic Parkinson’s Disease (PD) cases and 14 Controls. Our dataset comprises ∼84K nuclei, representing all major cell types of the brain, allowing us to obtain a transcriptome-level characterization of these cell types. Importantly, we identify multiple subpopulations for each cell type and describe specific gene sets that provide insights into the differing roles of these subpopulations. Our findings reveal a significant decrease in neuronal cells in PD samples, accompanied by an increase in glial cells and T cells. Subpopulation analyses demonstrate a significant depletion of tyrosine hydroxylase (TH) enriched astrocyte, microglia and oligodendrocyte populations in PD samples, as well as TH enriched neurons, which are also depleted. Moreover, marker gene analysis of the depleted subpopulations identified 28 overlapping genes, including those associated with dopamine metabolism (e.g., ALDH1A1, SLC6A3 & SLC18A2). Overall, our study provides a valuable resource for understanding the molecular mechanisms involved in dopaminergic neuron degeneration and glial responses in PD, highlighting the existence of novel subpopulations and cell type-specific gene sets.
first_indexed 2024-03-08T12:34:41Z
format Article
id doaj.art-ac5a812e7fc64915b2e68e33cecdd4a4
institution Directory Open Access Journal
issn 1750-1326
language English
last_indexed 2024-04-24T16:13:33Z
publishDate 2024-01-01
publisher BMC
record_format Article
series Molecular Neurodegeneration
spelling doaj.art-ac5a812e7fc64915b2e68e33cecdd4a42024-03-31T11:35:30ZengBMCMolecular Neurodegeneration1750-13262024-01-0119112410.1186/s13024-023-00699-0Unravelling cell type-specific responses to Parkinson’s Disease at single cell resolutionAraks Martirosyan0Rizwan Ansari1Francisco Pestana2Katja Hebestreit3Hayk Gasparyan4Razmik Aleksanyan5Silvia Hnatova6Suresh Poovathingal7Catherine Marneffe8Dietmar R. Thal9Andrew Kottick10Victor J. Hanson-Smith11Sebastian Guelfi12William Plumbly13T. Grant Belgard14Emmanouil Metzakopian15Matthew G. Holt16VIB Center for Brain & Disease Research, KU LeuvenUK Dementia Research Institute, Department of Clinical Neurosciences, University of CambridgeVIB Center for Brain & Disease Research, KU LeuvenVerge GenomicsArmenian Bioinformatics InstituteArmenian Bioinformatics InstituteUK Dementia Research Institute, Department of Clinical Neurosciences, University of CambridgeVIB Center for Brain & Disease Research, KU LeuvenVIB Center for Brain & Disease Research, KU LeuvenLaboratory for Neuropathology, Department of Imaging and Pathology and Leuven Brain Institute, KU Leuven, and Department of Pathology, UZ LeuvenVerge GenomicsVerge GenomicsVerge GenomicsUK Dementia Research Institute, Department of Clinical Neurosciences, University of CambridgeThe Bioinformatics CROUK Dementia Research Institute, Department of Clinical Neurosciences, University of CambridgeVIB Center for Brain & Disease Research, KU LeuvenAbstract Parkinson’s Disease (PD) is the second most common neurodegenerative disorder. The pathological hallmark of PD is loss of dopaminergic neurons and the presence of aggregated α-synuclein, primarily in the substantia nigra pars compacta (SNpc) of the midbrain. However, the molecular mechanisms that underlie the pathology in different cell types is not currently understood. Here, we present a single nucleus transcriptome analysis of human post-mortem SNpc obtained from 15 sporadic Parkinson’s Disease (PD) cases and 14 Controls. Our dataset comprises ∼84K nuclei, representing all major cell types of the brain, allowing us to obtain a transcriptome-level characterization of these cell types. Importantly, we identify multiple subpopulations for each cell type and describe specific gene sets that provide insights into the differing roles of these subpopulations. Our findings reveal a significant decrease in neuronal cells in PD samples, accompanied by an increase in glial cells and T cells. Subpopulation analyses demonstrate a significant depletion of tyrosine hydroxylase (TH) enriched astrocyte, microglia and oligodendrocyte populations in PD samples, as well as TH enriched neurons, which are also depleted. Moreover, marker gene analysis of the depleted subpopulations identified 28 overlapping genes, including those associated with dopamine metabolism (e.g., ALDH1A1, SLC6A3 & SLC18A2). Overall, our study provides a valuable resource for understanding the molecular mechanisms involved in dopaminergic neuron degeneration and glial responses in PD, highlighting the existence of novel subpopulations and cell type-specific gene sets.https://doi.org/10.1186/s13024-023-00699-0
spellingShingle Araks Martirosyan
Rizwan Ansari
Francisco Pestana
Katja Hebestreit
Hayk Gasparyan
Razmik Aleksanyan
Silvia Hnatova
Suresh Poovathingal
Catherine Marneffe
Dietmar R. Thal
Andrew Kottick
Victor J. Hanson-Smith
Sebastian Guelfi
William Plumbly
T. Grant Belgard
Emmanouil Metzakopian
Matthew G. Holt
Unravelling cell type-specific responses to Parkinson’s Disease at single cell resolution
Molecular Neurodegeneration
title Unravelling cell type-specific responses to Parkinson’s Disease at single cell resolution
title_full Unravelling cell type-specific responses to Parkinson’s Disease at single cell resolution
title_fullStr Unravelling cell type-specific responses to Parkinson’s Disease at single cell resolution
title_full_unstemmed Unravelling cell type-specific responses to Parkinson’s Disease at single cell resolution
title_short Unravelling cell type-specific responses to Parkinson’s Disease at single cell resolution
title_sort unravelling cell type specific responses to parkinson s disease at single cell resolution
url https://doi.org/10.1186/s13024-023-00699-0
work_keys_str_mv AT araksmartirosyan unravellingcelltypespecificresponsestoparkinsonsdiseaseatsinglecellresolution
AT rizwanansari unravellingcelltypespecificresponsestoparkinsonsdiseaseatsinglecellresolution
AT franciscopestana unravellingcelltypespecificresponsestoparkinsonsdiseaseatsinglecellresolution
AT katjahebestreit unravellingcelltypespecificresponsestoparkinsonsdiseaseatsinglecellresolution
AT haykgasparyan unravellingcelltypespecificresponsestoparkinsonsdiseaseatsinglecellresolution
AT razmikaleksanyan unravellingcelltypespecificresponsestoparkinsonsdiseaseatsinglecellresolution
AT silviahnatova unravellingcelltypespecificresponsestoparkinsonsdiseaseatsinglecellresolution
AT sureshpoovathingal unravellingcelltypespecificresponsestoparkinsonsdiseaseatsinglecellresolution
AT catherinemarneffe unravellingcelltypespecificresponsestoparkinsonsdiseaseatsinglecellresolution
AT dietmarrthal unravellingcelltypespecificresponsestoparkinsonsdiseaseatsinglecellresolution
AT andrewkottick unravellingcelltypespecificresponsestoparkinsonsdiseaseatsinglecellresolution
AT victorjhansonsmith unravellingcelltypespecificresponsestoparkinsonsdiseaseatsinglecellresolution
AT sebastianguelfi unravellingcelltypespecificresponsestoparkinsonsdiseaseatsinglecellresolution
AT williamplumbly unravellingcelltypespecificresponsestoparkinsonsdiseaseatsinglecellresolution
AT tgrantbelgard unravellingcelltypespecificresponsestoparkinsonsdiseaseatsinglecellresolution
AT emmanouilmetzakopian unravellingcelltypespecificresponsestoparkinsonsdiseaseatsinglecellresolution
AT matthewgholt unravellingcelltypespecificresponsestoparkinsonsdiseaseatsinglecellresolution